ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.035,69
-1,57%
US Dollar vs BRL
5,1954
1,50%
Bitcoin
60.415,26
-5,36%
Brent Oil
85,895
-1,59%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) Notícias

MNMD Mind Medicine MindMed Inc

9,1182
0,0882 (0,98%)
Após o horário de negociação
Última atualização: 18:49:44
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Mind Medicine MindMed Inc MNMD NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,0882 0,98% 9,1182 18:49:44
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
9,01 8,81 9,55 9,52 9,03
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/04/202408:00BWMindMed to Present at Upcoming May Medical Conferences
02/04/202408:00BWMindMed to Present at Upcoming April Medical Conferences
01/04/202418:00BWMindMed Announces Voluntary Delisting from Cboe Canada
11/03/202408:00BWMindMed to Participate in the Leerink Partners 2024 Global..
07/03/202409:13BWMind Medicine (MindMed) Inc. Announces Pricing of..
07/03/202408:00BWMindMed Receives FDA Breakthrough Therapy Designation and..
01/03/202411:00BWMindMed to Host Conference Call and Webcast to Discuss Data..
28/02/202409:05BWMindMed Reports 2023 Financial Results and Business Updates
22/02/202409:00BWMindMed to Host Conference Call and Webcast to Discuss 2023..
07/02/202409:00BWMindMed to Participate in the 34th Annual Oppenheimer..
08/01/202409:45BWMindMed Announces Business Update and Anticipated Milestones..
14/12/202309:30BWMindMed Announces Positive Topline Results from Phase 2b..
02/11/202317:01BWMindMed Reports Third Quarter 2023 Financial Results and..
26/10/202308:30BWMindMed to Host Conference Call and Webcast to Discuss Third..
24/10/202308:30BWMindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
03/10/202308:30BWMindMed to Present Data on the Preclinical Activity of..
14/09/202308:30BWMindMed to Participate in the TD Cowen 3rd Annual Novel..
12/09/202308:30BWMindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
28/08/202308:30BWMindMed to Participate at September Investor Conferences
14/08/202308:30BWMindMed Secures $50.0 Million Credit Facility with K2..
03/08/202317:01BWMindMed Reports Second Quarter 2023 Financial Results and..
03/08/202308:30BWMindMed Announces Exclusive License Agreement With Catalent..
31/07/202309:30BWMindMed to Host Conference Call and Webcast to Discuss..
22/06/202309:30BWMindMed to Participate in the H.C. Wainwright 4th Annual..
21/06/202313:08BWMindMed Announces Election of All Six Company Nominees at..
20/06/202309:30BWMindMed Provides Overview of Clinical Progress and Corporate..
15/06/202317:23GLOBEFCM Denounces MindMed’s Manipulation of Corporate Machinery..
15/06/202311:45BWMindMed Adjourns Annual General Meeting of Shareholders
09/06/202310:00BWMindMed Urges Shareholders to Vote TODAY for Company..
08/06/202312:30BWLeading Proxy Advisory Firm Glass Lewis Recommends MindMed..
07/06/202309:07GLOBEFCM Plans for MM-120 (LSD) FDA Approval in 2026 And Extends..
07/06/202309:00BWMindMed to Host Investor Day June 2023
05/06/202309:00BWLeading Proxy Advisory Firm ISS Recommends MindMed..
05/06/202308:00PRNUSCedar Clinical Research, by Numinus, the top enrolling..
02/06/202317:17GLOBEFCM Predicts Psychedelic Revolution In 2024: Urges..
01/06/202308:00BWMindMed to Participate at Upcoming Investor Conferences
30/05/202317:17GLOBEFCM Pledges to Lock Up its MindMed Shares Until June 2025 to..
25/05/202317:57GLOBEFCM Concerned MindMed’s Mismanagement Threatens Mental..
25/05/202317:00BWMindMed Releases Investor Presentation Highlighting How the..
25/05/202309:00BWMindMed Publishes Report by Leading FDA Experts Validating..
24/05/202308:00BWMindMed to Present Data on the Preclinical Activity of..
17/05/202317:01BWMindMed Announces Enrollment Milestone in Phase 2b Trial of..
15/05/202309:24GLOBEFCM Director Nominees Will Put MindMed Drug Development..
05/05/202309:08GLOBEFCM Releases Letter to Fellow MindMed Shareholders..
04/05/202317:02BWMindMed Reports First Quarter 2023 Financial Results and..
02/05/202309:00BWMindMed Sends Letter to Shareholders Highlighting Company’s..
01/05/202317:01BWMindMed to Host Conference Call and Webcast to Discuss First..

Seu Histórico Recente

NASDAQ
MNMD
Mind Medicine MindMed
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados